Trifluoromethylation of alkyl electrophiles with <sup>11</sup>C- or <sup>18</sup>F-labeled fluoroform for PET applications.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41411425.
- Also identified by DOI 10.1126/science.ady2969 and PMC identifier 12731722.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Continued development of positron emission tomography (PET) tracers is essential for advancing molecular imaging in biomedical research and clinical diagnostics. A long-standing limitation in radiochemistry for PET imaging has been the lack of general methods for radiolabeling trifluoromethyl (CF<sub>3</sub>) groups at C(sp<sup>3</sup>) sites, despite their growing prevalence in bioactive molecules and radiopharmaceuticals. Here, we present a general approach for late-stage installation of either a [<sup>18</sup>F]CF<sub>3</sub> or [<sup>11</sup>C]CF<sub>3</sub> group at a C(sp<sup>3</sup>) site. This method leverages unusual copper-mediated radiotrifluoromethylation of alkyl halides and alkyl carboxylic acids by halogen atom transfer and photoredox catalysis, respectively. More than 50 complex molecules and pharmaceutical agents were efficiently labeled with fluorine-18 (<sup>18</sup>F) or carbon-11 (<sup>11</sup>C). Two long-sought-after radioligands, [<sup>18</sup>F]SL25.1188 and [<sup>18</sup>F]PS13, were synthesized, providing longer-lived <sup>18</sup>F analogs of their <sup>11</sup>C counterparts with great promise for human PET imaging.
Medical subject headings
- Carbon Radioisotopes
- Chlorofluorocarbons, Methane
- Fluorine Radioisotopes
- Isotope Labeling
- Positron-Emission Tomography
- Radiopharmaceuticals
- Molecular Imaging